Pharmaceutical Manufacturing in America

The Pharmaceutical Research and Manufacturers of America, PhRMA, represents the nation's leading biopharmaceutical research companies.

Brand Name Pharmaceutical Manufacturing in the US - IBISWorld

How many businesses are there in the Brand Name Pharmaceutical Manufacturing industry in the US? IBISWorld's statistic shows that as of 2024 ...

Top 10 Pharmaceutical Companies in the US - MRL Consulting Group

Top 10 Pharmaceutical Companies in the US · 1. Johnson & Johnson. Johnson & Johnson leads our compilation of the top 10 pharmaceutical companies ...

Pharmaceutical Manufacturing in America: A Brief History

Abstract: This article reviews the history of drug manufacturing and changes in the compounding of drugs by pharmacies in the United States and outlines ...

NAM Study: U.S. Pharmaceutical Manufacturing Strength Requires ...

The National Association of Manufacturers released a new study, “Creating Cures, Saving Lives,” which demonstrates the urgency of strengthening US ...

Geographic concentration of pharmaceutical manufacturing

In 2019, the U.S. Food and Drug Administration (FDA) shared data illustrating U.S. reliance on foreign active pharmaceutical ingredient (API) ...

U.S. pharmaceutical industry - statistics & facts - Statista

Prescription drug prices in the United States are among the highest in the world, and recent years have been especially profitable for the American ...

Considerations for FDA's New Advanced Pharmaceutical ...

The U.S. has significant expertise in AMTs—more than 80 percent of drugs currently made using AMTs are produced in the U.S. After initial ...

Top 6 States and Territories in Pharmaceutical and Medicine ...

Top 6 States and Territories in Pharmaceutical and Medicine Manufacturing Exports ; $17.9 · $16.4 · $11.1 · $9.3.

Pharmaceutical Manufacturing in America: A Brief History

Broadly, as pharmaceutical firms turned to a business model built around research and intellectual property production, and as pharmacists shifted from ...

A Blueprint for Enhancing the Security of the U.S. Pharmaceutical ...

The United States already plays an important role in this supply chain, with generic companies providing more than 52,000 jobs at nearly. 150 facilities, and ...

Pharmaceutical Countermeasures Infrastructure (PCI)

PCI is strengthening U.S. preparedness by increasing domestic vaccine manufacturing capabilities at the speed and scale to meet public health emergencies, ...

The U.S. Needs to Reimagine Its Pharma Supply Chain

We must reimagine a domestic, end-to-end solution for turning APIs into vital finished medicines while at the same time lowering costs and waste and improving ...

Pharma Manufacturing: Home

... pharmaceutical companies are tackling drug development, scale-up and manufacturing ... pharma landscape is always pushing us to shift our perspectives. Bringing ...

Advanced Pharmaceutical Manufacturing Tech Hub

... pharmaceuticals are manufactured in the United States. The APM Tech Hub seeks to rapidly expand production of active pharmaceutical ingredients (API) and ...

New NAM Report Highlights the Impact and Importance of ...

Pharmaceutical and medicine manufacturing directly employs an estimated 267,000 workers in the United States and supports nearly 1.9 million more jobs across ...

Top 10 Pharmaceutical & Medical Device Industry Hubs in the USA

Companies include – Sanofi, Biogen, Shire, Novartis, Boston Scientific. Lab Space (in square feet): 26.8m; NIH Funding 2018/19: $2.45b; Venture Capital Funding ...

Is the future of US pharma manufacturing domestic? - Recon Strategy

The White House has announced a series of funded initiatives aimed at improving the US's domestic market share, creating “good jobs,” and reducing supply chain ...

Biopharmaceutical Manufacturing - PhRMA

As of April 2023, biopharmaceutical companies and their suppliers operated 1,580 production facilities across the country, in 48 states and Puerto Rico. Further ...

Brand Name Pharmaceutical Manufacturing in the US - IBISWorld

Revenue has been growing at a CAGR of 3.7% over the past five years to an estimated $261.2 billion, including expected growth of 1.4% in 2024.